Home » Topics » BioWorld Science

BioWorld Science
RSS

New NK3/NK4 antagonist in the pipeline at SKB

Nov. 20, 1997

Phase II begins for psoriasis vaccine

Nov. 20, 1997

Phase II results with T-cell receptor peptides in RA promising

Nov. 20, 1997

HMR and MediGene collaborate on cancer gene therapies

Nov. 20, 1997

Extensive preclinical results described for new NK2 antagonist

Nov. 20, 1997

FDA advisory committee to review rotavirus vaccine

Nov. 20, 1997

Nortran and Bridge Pharma to develop dermal anesthetics

Nov. 20, 1997

Life Medical Sciences: Q2 and nine-month 1997 highlights

Nov. 20, 1997

FDA advisory committee recommends approval of Prandin

Nov. 20, 1997

Matritech: Q3 1997 highlights

Nov. 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...